Referencias

1. Weisbrod BA, Test MA, Stein LI. Alternative to mental hospital treatment. II. Economic benefit-cost analysis. Arch Gen Psychiatry 1980;37(3):411-9.
2. Weisbrod BA. A guide to benefit-cost analysis as seen through a controlled experiment in treating the mentally ill. J Health Polit Policy Law 1983;7:808-45.
3. Defensor del Pueblo. Situación Jurídica y Asistencial del Enfermo Mental en España. Madrid: Publicaciones de la Oficina del Defensor del Pueblo; 1992.
4. Goldberg D. Cost-effectiveness in the treatment of patients with schizophrenia. Acta Psychiatr Scand 1994;89 Suppl 382:89-92.
5. Knapp M. Costs and outcomes: Variations and comparisons. En: Knapp M., editor. The economic evaluation of mental health care. Aldershot: Ashgate Publishing Co.; 1995.
6. Gulbinat W, Manderscheid R, Beigel A, Costa e Silva JA. A multinational strategy on mental health policy and care. A WHO collaborative initiative and consultative program. En: Moscarelli M, Rupp A, Sartorius N, editores. The Handbook of Mental Health Economics and Health Policies, Vol I: Schizophrenia. Chichester: J Wiley & Sons; 1996.
7. González de Ghaves M. Posibles indicadores para el análisis de las reformas psiquiátricas. En: Aparicio V, editor. Evaluación de Servicios de Salud Mental. Madrid: Asociación Española de Psiquiatría; 1993.
8. Shore JH. Community Psychiatry. En: Kaplan HI, Sadock BJ, editores. Comprehensive Textbook of Psychiatry/V. Baltimore: Williams & Wilkins; 1989.
9. Davis JM, Barter JT, Kane JM. Antipsychotic drugs. En: Kaplan HI, Sadock BJ, editores. Comprehensive Textbook of Psychiatry/V. Baltimore: Williams & Wilkins; 1989.
10. Talbott JA. Stopping the revolving door. A study of readmission to a state hospital. Psychiatr Q 1974;48:599-604.
11. O’Driscoll C. The TAPS Project 7: Mental hospital closure-a literature review of outcome studies and evaluative techniques. Br J Psychiatry 1993;162 Suppl 19:7-19.
12. Salvador L, Leonsegui I, Gibert J. Aspectos psicofarmacológicos de la esquizofrenia. II. Optimización del uso de antipsicóticos convencionales en el tratamiento de la esquizofrenia. Monogr Psiquiatr 1992;6(5):10-5.
13. World Health Organization. International Classification of Impairments, Disabilities and Handicaps. Geneva: WHO; 1980.
14. Veltro F, Magliano L, Lobrace S, Morosini PL. Burden on key relatives of patients with schizophrenia vs neurotic disorders: a pilot study. Soc Psychiatry Psychiatr Epidemiol 1994;29:66-70.
15. Franks DD. Economic contribution of families caring for persons with severe and persistent mental illness. Adm Policy Men Health 1990;18:9-18.
16. Hargreaves WA, Shumway M. Effectiveness of services for the severely mentally ill. U.S. En: Taube CA, Mechanic D, Hohmann A, editores. The future of mental health services research. Washington: Department of Health & Human Services; 1989.
17. De Jong P. The WHO-International Classification of Mental Health Care. Preliminary version. Groningen: Departament of Social Psychiatry, University of Groningen; 1996.
18. Hargreaves WA, Shumway M, Hu TW. Measuring service use and delivery. En: Moscarelli M, Rupp A, Sartorius N, editores. Mental Health Economics. Vol 1: Schizophrenia. London: Willey; 1996.
19. Stein LI, Test MA. Alternative to mental hospital treatment. I: Conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry 1980;37:392-7.
20. Munizza C, De Jong P, Perris C, Salvador L, Thornicroft G, Von Cranach M, et al. Psychiatric Rehabilitation-Standardization of procedures for the assessment of activities and costs/benefits. En: Baert AE, Baig SS, Bardoux C, Fracchia GN, Hallen M, Le Dour O, et al. editores. Biomedical and Health Research. The BIOMED I Programme. Amsterdam: IOS Press; 1995.